These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 6130595

  • 1. The effect on HDL cholesterol of oxprenolol and atenolol.
    Kjeldsen SE, Eide I, Leren P, Foss OP, Holme I, Eriksen IL.
    Scand J Clin Lab Invest; 1982 Sep; 42(5):449-53. PubMed ID: 6130595
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Cardiovasc Pharmacol; 1982 Sep; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [Abstract] [Full Text] [Related]

  • 3. Effects of posture on serum cholesterol fractions, cholesterol ratio and triglycerides.
    Kjeldsen SE, Eide I, Leren P, Foss OP.
    Scand J Clin Lab Invest; 1983 Apr; 43(2):119-21. PubMed ID: 6577578
    [Abstract] [Full Text] [Related]

  • 4. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H, Schmidt J, Derendorf H.
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [Abstract] [Full Text] [Related]

  • 5. The biochemical effects of antihypertensive agents and the impact on atherosclerosis.
    Lowenstein J, Neusy AJ.
    J Cardiovasc Pharmacol; 1982 Jan; 4 Suppl 2():S262-4. PubMed ID: 6177970
    [No Abstract] [Full Text] [Related]

  • 6. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982 Jan; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

  • 7. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T, Lehtonen A.
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [Abstract] [Full Text] [Related]

  • 8. [Rapid effect of glucuronyl glucosamine glycan sulfate on the blood levels of HDL-cholesterol in vascular diseases].
    Ferlito S, La Spina E, Cultrera E, Puleo F, Carrà G.
    Arch Sci Med (Torino); 1982 Jun; 139(2):175-81. PubMed ID: 7138283
    [Abstract] [Full Text] [Related]

  • 9. [Clinical significance of HDL-cholesterol].
    Reuter W, Herrmann W.
    Z Gesamte Inn Med; 1981 Jul 15; 36(14):473-9. PubMed ID: 6944971
    [Abstract] [Full Text] [Related]

  • 10. Effect of mepindolol on serum lipids.
    Martignoni A, Perani G, Finardi G, Mastropasqua E, Fogari R.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov 15; 20(11):543-5. PubMed ID: 7174157
    [Abstract] [Full Text] [Related]

  • 11. Atenolol and metoprolol: comparison of effects on blood pressure and serum lipoproteins, and side effects.
    Rössner S, Weiner L.
    Eur J Clin Pharmacol; 1983 Nov 15; 24(5):573-7. PubMed ID: 6873132
    [Abstract] [Full Text] [Related]

  • 12. [Adrenergic mechanisms and their significance for plasma lipid concentrations].
    Day JL.
    Wien Med Wochenschr; 1982 Nov 15; 132 Spec No 2():19-22. PubMed ID: 6132497
    [No Abstract] [Full Text] [Related]

  • 13. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI, Bhatnagar D, Durrington PN, Prais H, Haynes B, Morgan J, Borthwick L.
    Eur J Clin Nutr; 1994 Dec 15; 48(12):859-65. PubMed ID: 7889894
    [Abstract] [Full Text] [Related]

  • 14. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF.
    J Cardiovasc Pharmacol; 1982 Dec 15; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [Abstract] [Full Text] [Related]

  • 15. Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension.
    Sasaki J, Handa K, Arakawa K.
    Clin Ther; 1989 Dec 15; 11(5):580-3. PubMed ID: 2478285
    [Abstract] [Full Text] [Related]

  • 16. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R, Zoppi A, Pasotti C, Poletti L, Tettamanti F, Malamani G, Corradi L.
    J Cardiovasc Pharmacol; 1989 Dec 15; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the hypotensive and metabolic effects of 50 and 100 mg atenolol per day.
    Lithell H, Aberg H, Selinus I.
    Drugs Exp Clin Res; 1986 Dec 15; 12(5):393-6. PubMed ID: 3720523
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients. Swedish-Finnish Study Group.
    Thulin T, Lehtonen A, Dahlöf C, Nilsson-Ehle P, Engqvist L, Lagerstedt C, Berglund E.
    Int J Clin Pharmacol Ther; 1999 Jan 15; 37(1):28-33. PubMed ID: 10027480
    [Abstract] [Full Text] [Related]

  • 19. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia].
    Deng Z, Liu B, Zhou J, Zhang Z, Liu Y, Bai H.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct 15; 34(4):704-7. PubMed ID: 14619587
    [Abstract] [Full Text] [Related]

  • 20. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W, Reuter W.
    Z Gesamte Inn Med; 1982 Dec 15; 37(24):830-3. PubMed ID: 6963524
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.